News
HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $92 Price Target
26 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Needham Reiterates Buy on Apellis Pharmaceuticals, Maintains $85 Price Target
25 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Wedbush Maintains Neutral on Apellis Pharmaceuticals, Lowers Price Target to $57
17 Apr 24
News, Price Target, Analyst Ratings
Expert Ratings For Apellis Pharmaceuticals
15 Apr 24
Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $92 Price Target
15 Apr 24
News, Price Target, Reiteration, Analyst Ratings
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $3,000 Today
10 Apr 24
News, Trading Ideas
Needham Reiterates Buy on Apellis Pharmaceuticals, Maintains $85 Price Target
9 Apr 24
News, Price Target, Reiteration, Analyst Ratings
$1000 Invested In This Stock 5 Years Ago Would Be Worth $3,000 Today
29 Mar 24
News, Trading Ideas
Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals
27 Mar 24
Analyst Ratings
Mizuho Maintains Neutral on Apellis Pharmaceuticals, Maintains $60 Price Target
27 Mar 24
News, Price Target, Analyst Ratings
Peering Into Apellis Pharmaceuticals's Recent Short Interest
15 Mar 24
Short Sellers, Short Ideas, Trading Ideas
JP Morgan Maintains Overweight on Apellis Pharmaceuticals, Raises Price Target to $79
6 Mar 24
News, Price Target, Analyst Ratings
UBS Maintains Buy on Apellis Pharmaceuticals, Raises Price Target to $89
4 Mar 24
News, Price Target, Analyst Ratings
Deep Dive Into Apellis Pharmaceuticals Stock: Analyst Perspectives (18 Ratings)
28 Feb 24
Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Apellis Pharmaceuticals, Maintains $92 Price Target
28 Feb 24
News, Price Target, Reiteration, Analyst Ratings
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
28 Feb 24
News, Price Target, Small Cap, Markets, Analyst Ratings, Trading Ideas
Wedbush Maintains Neutral on Apellis Pharmaceuticals, Raises Price Target to $67
28 Feb 24
News, Price Target, Analyst Ratings
Apellis Pharmaceuticals Q4 EPS $(0.73) Misses $(0.69) Estimate, Sales $146.38M Beat $143.59M Estimate
27 Feb 24
Earnings, News
Earnings Scheduled For February 27, 2024
27 Feb 24
Earnings
Here's How Much You Would Have Made Owning Apellis Pharmaceuticals Stock In The Last 5 Years
22 Feb 24
News, Trading Ideas
Press releases
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
1 May 24
News, Health Care, Press Releases, General
Apellis Announces Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by European Medicines Agency (EMA)
26 Apr 24
Press Releases, General
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 Apr 24
Markets, Press Releases
Investigation Alert: Cummins, Apellis Pharmaceuticals, Inspire Medical, and Applied Digital - Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
19 Mar 24
News, Legal, Press Releases
Investigation Alert Driven Brands Holdings, Apellis Pharmaceuticals, Inspire Medical, and Applied Digital: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below
5 Mar 24
News, Legal, Press Releases
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 24
News, Press Releases